This project is no longer accepting applications. Subscribe to our newsletter to be notified of new projects!
In this Project, students will focus on designing and optimizing a CRISPR/Cas9 gene editing strategies for a specific target gene leading to a comprehensive report on a plan for successful gene modification.
Embark on Precision Guide Quest! CRISPR/Cas9 gene editing revolutionized the biotech industry with its precise and versatile approach to modifying DNA. This technology utilizes a guide RNA to direct the Cas9 enzyme to specific genomic locations, where it induces double-strand breaks that can be repaired to introduce desired genetic changes. CRISPR/Cas9 has become indispensable in various industries, particularly in biomedicine, agriculture, and biotechnology, due to its ability to precisely edit genes, model diseases, develop novel therapeutics, and improve crop traits. Its efficiency, affordability, and scalability have propelled it to the forefront of genetic engineering, promising breakthroughs in treating genetic disorders, enhancing crop resilience, and advancing personalized medicine.
In this Build Project, you will create a meticulous gene editing strategy using CRISPR/Cas9 for a specific target gene crucial in disease research. You will design guide RNAs to precisely direct the Cas9 enzyme to the desired genomic location, enabling them to induce precise genetic modifications. Additionally, you will explore and select optimal delivery methods to introduce the CRISPR/Cas9 components into target cells or organisms, ensuring efficient editing while minimizing off-target effects with the insights in in vivo studies. Through critical thinking and problem-solving skills, you will develop a comprehensive understanding of CRISPR/Cas9 editing strategies and gain valuable skills applicable to the biotech industry. You will be creating a pitch deck at the end of the project which will showcase your skillset with a flow of understanding and skills learnt in this project which are the gateway to the coveted roles in the biotech industry and will act as a catalyst for a rewarding career at the forefront of genetic innovation!
Get access to all of our Build projects, including this one, by creating your Build account!
Get started by submitting your application.
We'll notify you of new projects via email. In the meantime, you can explore our resources and learn more about our Fellows.
I am Harshi Gangrade, a senior research associate at CRISPR Therapeutics. My focus is on manipulating the expression of the Angiotensinogen gene to manage refractory hypertension. Originally from India, I completed my Bachelor’s in Biotechnology at D.Y. Patil University before pursuing my Masters in Biotechnology at Johns Hopkins University in the United States, graduating in 2020. Following my studies, I conducted research under Dr. Emmanouil Tampakakis in a cardiology lab at Johns Hopkins Medical Institute, where I contributed to several projects and authored multiple research papers. After two years, I transitioned to industrial research to gain insights into the commercial aspects and the translation of biotechnology from laboratory experiments to practical applications. Joining CRISPR Therapeutics in 2022 has provided me with valuable opportunities in this regard, and I have found great satisfaction in my work here ever since.